SJ
Saurabh Juneja
About Saurabh Juneja
Data last updated:
Saurabh Juneja is a Director at Farlex Pharmaceuticals Private Limited (since 2019), Director at Kesar Drugs Private Limited (since 2022) and Director at Oxermed Labs Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹16.81 Cr; the largest is Farlex Pharmaceuticals Private Limited at ₹15.67 Cr (FY 2025). Earlier, Saurabh Juneja was a Director at Krishna Intercontinental Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Nov 2019 | 2014 | ₹15.67 Cr (FY 2025) | Active | |
| Director | 10 Oct 2022 | 2022 | ₹70.9 Lakh (FY 2025) | Active | |
| Director | 03 May 2021 | 2021 | ₹42.7 Lakh (FY 2024) | Active | |
| Director | 25 Aug 2026 | 2026 | Active | ||
| Director | 10 Dec 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 May 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Saurabh Juneja
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aarti | 07752020 | Farlex Pharmaceuticals Private Limited , Farlex Lifesciences Private Limited | Director |
| Sajjan Kumar | 05263821 | Kesar Drugs Private Limited | Director |
| Balinder Kumar | 02466691 | Oxermed Labs Private Limited | Director |
| Harishender Mohan | 05109389 | Oxermed Labs Private Limited | Director |
| Ashok Kumar | 11913840 | Kesar Aerosols Private Limited | Director |
| Kunal Garg | 11058280 | Kesar Aerosols Private Limited | Director |
| Om Prakash | 11913839 | Kesar Aerosols Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saurabh Juneja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saurabh Juneja
Saurabh Juneja currently holds 5 directorships: Farlex Pharmaceuticals Private Limited (Director, since 09 Nov 2019, revenue ₹15.67 Cr (FY 2025)); Kesar Drugs Private Limited (Director, since 10 Oct 2022, revenue ₹70.9 Lakh (FY 2025)); Oxermed Labs Private Limited (Director, since 03 May 2021, revenue ₹42.7 Lakh (FY 2024)); Kesar Aerosols Private Limited (Director, since 25 Aug 2026); Farlex Lifesciences Private Limited (Director, since 10 Dec 2019).
Saurabh Juneja was first appointed on 30 May 2013 as Director at Krishna Intercontinental Private Limited. The most recent appointment on record is 25 Aug 2026 at Kesar Aerosols Private Limited.
The 3 current companies of Saurabh Juneja that report revenue have a combined latest revenue of ₹16.81 Cr: Farlex Pharmaceuticals Private Limited ₹15.67 Cr (FY 2025); Kesar Drugs Private Limited ₹70.9 Lakh (FY 2025); Oxermed Labs Private Limited ₹42.7 Lakh (FY 2024).
Saurabh Juneja held 1 earlier board appointment: Krishna Intercontinental Private Limited (Director, from 30 May 2013).
The current boards of Saurabh Juneja's companies include Aarti (Farlex Pharmaceuticals Private Limited), Sajjan Kumar (Kesar Drugs Private Limited), Balinder Kumar (Oxermed Labs Private Limited), Harishender Mohan (Oxermed Labs Private Limited), Ashok Kumar (Kesar Aerosols Private Limited), Kunal Garg (Kesar Aerosols Private Limited), among others.